DNM1L and lung adenocarcinoma: Results showed that the CRISPR/Cas9 lentiviral transduction did not affect cell cycle progression in either CL1‐0 or A549 (Fig. S8), and further revealed an increased percentage of cells at S/G2/M phases in DNM1L‐KO lung adenocarcinoma cell lines (Fig. 5A,B), indicating that DRP1 activity is required for correct cell cycle progression.